Literature DB >> 23859878

A comparative study: In vitro effects of EPA and DHA on immune functions of head-kidney macrophages isolated from large yellow croaker (Larmichthys crocea).

Qingfei Li1, Qinghui Ai, Kangsen Mai, Wei Xu, Yuefu Zheng.   

Abstract

Comparative effects of different concentrations of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on immune responses of head-kidney macrophages isolated from large yellow croaker were studied in vitro. After exposing to serum-free medium for 1 day, cultured cells were incubated in medium supplemented with graded levels of EPA or DHA (0, 5, 25, 100, 200 and 1000 μM, respectively) in the form of fatty acid bovine serum albumin (FA-BSA) complex for 12 h, 24 h and 36 h, respectively. Control samples were incubated in the absence of EPA or DHA (2% bovine serum albumin, BSA). Following stimulation, cell viability, lipid peroxidation, secretary phopholipase A2 (sPLA2) and prostaglandin E2 (PGE2) production as well as some immune parameters including phagocytosis, respiratory burst activity and interleukin 1β (IL-1β) production were determined. Results showed that EPA and DHA affected cell viability in dose-dependent and time-dependent manners. In particular, cell viability was significantly decreased after 24 h and 36 h incubation with 1000 μM EPA or DHA (P < 0.05). Higher levels of EPA (200 and 1000 μM) caused a significant increase in the production of malondialdehyde (MDA) (P < 0.05), while DHA did not significantly affect the MDA production. EPA significantly increased the intracellular superoxide anion synthesis which, on the contrary, was significantly reduced by DHA. Phagocytosis percentage (PP) values were significantly higher in treatments with 5 μM DHA (P < 0.05), but significantly decreased by 200 and 1000 μM EPA and DHA compared to the control group (P < 0.05). Decreased PGE2 production was produced by cells treated with relatively low doses of EPA or DHA. When high levels of stimulants (1000 μM EPA or DHA) were used, PGE2 levels were elevated and reached a significant level (P < 0.05). Both EPA and DHA significantly inhibited the production of sPLA2, where DHA exerted the more potent inhibitory effects than EPA. No pronounced effect was observed on IL-1β production among all the treatments, and IL-1β level in cell culture supernatant was fairly low (only approximately 6 pg/ml). Those findings suggested that EPA and DHA could influence the immunity and physiological conditions of macrophages from head kidney of large yellow croaker in vitro.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Keywords:  Eicospentaenoic (EPA) or docosahexaenoic (DHA); Immune response; In vitro; Larmichthys crocea; Macrophage

Mesh:

Substances:

Year:  2013        PMID: 23859878     DOI: 10.1016/j.fsi.2013.07.004

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  11 in total

1.  Docosahexaenoic Acid Alleviates Palmitic Acid-Induced Inflammation of Macrophages via TLR22-MAPK-PPARγ/Nrf2 Pathway in Large Yellow Croaker (Larimichthys crocea).

Authors:  Dan Xu; Kun Cui; Qingfei Li; Si Zhu; Junzhi Zhang; Shengnan Gao; Tingting Hao; Kangsen Mai; Qinghui Ai
Journal:  Antioxidants (Basel)       Date:  2022-03-31

2.  Whole-genome single-nucleotide polymorphism (SNP) marker discovery and association analysis with the eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) content in Larimichthys crocea.

Authors:  Shijun Xiao; Panpan Wang; Linsong Dong; Yaguang Zhang; Zhaofang Han; Qiurong Wang; Zhiyong Wang
Journal:  PeerJ       Date:  2016-12-21       Impact factor: 2.984

3.  Role of Bacillus licheniformis VS16-Derived Biosurfactant in Mediating Immune Responses in Carp Rohu and its Application to the Food Industry.

Authors:  Sib Sankar Giri; Shib Sankar Sen; Jin Woo Jun; V Sukumaran; Se Chang Park
Journal:  Front Microbiol       Date:  2017-03-28       Impact factor: 5.640

4.  TIR Domain-Containing Adaptor-Inducing Interferon-β (TRIF) Participates in Antiviral Immune Responses and Hepatic Lipogenesis of Large Yellow Croaker (Larimichthys Crocea).

Authors:  Si Zhu; Xiaojun Xiang; Xiang Xu; Shengnan Gao; Kangsen Mai; Qinghui Ai
Journal:  Front Immunol       Date:  2019-10-30       Impact factor: 7.561

5.  Oil from transgenic Camelina sativa as a source of EPA and DHA in feed for European sea bass (Dicentrarchus labrax L.).

Authors:  M B Betancor; A MacEwan; M Sprague; X Gong; D Montero; L Han; J A Napier; F Norambuena; M Izquierdo; D R Tocher
Journal:  Aquaculture       Date:  2021-01-15       Impact factor: 4.242

Review 6.  Potential Applications of Fluorescence-Activated Cell Sorting (FACS) and Droplet-Based Microfluidics in Promoting the Discovery of Specific Antibodies for Characterizations of Fish Immune Cells.

Authors:  Chenjie Fei; Li Nie; Jianhua Zhang; Jiong Chen
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

Review 7.  Pathways of lipid metabolism in marine algae, co-expression network, bottlenecks and candidate genes for enhanced production of EPA and DHA in species of Chromista.

Authors:  Alice Mühlroth; Keshuai Li; Gunvor Røkke; Per Winge; Yngvar Olsen; Martin F Hohmann-Marriott; Olav Vadstein; Atle M Bones
Journal:  Mar Drugs       Date:  2013-11-22       Impact factor: 5.118

8.  Polyunsaturated Fatty Acids Influence LPS-Induced Inflammation of Fish Macrophages Through Differential Modulation of Pathogen Recognition and p38 MAPK/NF-κB Signaling.

Authors:  Qingfei Li; Kun Cui; Mengjiao Wu; Dan Xu; Kangsen Mai; Qinghui Ai
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

9.  Oxidative status and intestinal health of gilthead sea bream (Sparus aurata) juveniles fed diets with different ARA/EPA/DHA ratios.

Authors:  R Magalhães; I Guerreiro; R A Santos; F Coutinho; A Couto; C R Serra; R E Olsen; H Peres; A Oliva-Teles
Journal:  Sci Rep       Date:  2020-08-14       Impact factor: 4.379

10.  Regulation of Free Fatty Acid Receptor 4 on Inflammatory Gene Induced by LPS in Large Yellow Croaker (Larimichthys crocea).

Authors:  Mengjiao Wu; Qingfei Li; Kangsen Mai; Qinghui Ai
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.